Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT
Outlook Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M | -13.11M | -14.46M |
Depreciation & Amortization | 29.1K | 28.8K | 28.8K | 28.67K | 28.2K | 28.2K | 11.22K | 11.19K | 11K | 10.78K | 51.47K | -51.27K | -51.09K | 50.87K | 50.67K | 48.18K | 82.17K | 81.12K |
Stock-Based Compensation | 1.72M | 3.67M | 1.41M | 1.4M | 1.31M | 1.27M | 1.39M | 1.38M | 1.38M | 1.39M | 1.38M | 1.37M | 3.76M | 1.2M | 1.4M | 1.2M | 1.13M | 1.15M |
Other Working Capital | -797.94K | 5.77M | 1.69M | -3.47M | -1.53M | -1.1M | -3.75M | 1.94M | -2.31M | 5.78M | 1.2M | -3.89M | -1.03M | 742.16K | 3.4M | -6.46M | -3.25M | -565.94K |
Other Non-Cash Items | 33.94M | -38.94M | -28.33M | -63.57M | 94.94M | 993K | 856.49K | 2.91M | 1.35K | 1.9M | 451.69K | 1.96M | 4.56M | 507.07K | 253.67K | 248.19K | 422.9K | -583.22K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 50.79K | -18.94K | 18.94K | n/a | n/a | n/a | -1.27M | -3.66M | 799.16K | -300.34K | 464.68K | 228.83K | 105.32K |
Change in Working Capital | -5.92M | 6.89M | 4.22M | -1.78M | -1.26M | -4.2M | -1.99M | 3.14M | -2.86M | 6.46M | 2.22M | -5.57M | 763.27K | 911.33K | 3.01M | -9.96M | -503.28K | 373.41K |
Operating Cash Flow | -16.58M | -10.97M | -16.98M | -19.51M | -19.27M | -13.03M | -12.74M | -13.22M | -8.11M | -8.9M | -10.25M | -21.1M | -14.33M | -10.99M | -8.99M | -20.19M | -11.75M | -13.32M |
Capital Expenditures | 3.00 | -5 | 3.00 | -3 | -3 | n/a | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 3.00 | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 189.97K | n/a | 4.27K | n/a | -1.08K | -3.18K | -3.08K | -2.98K | -2.89K | 19.78M | -5.68K | -11.6M | -308.33K | 9.59M | -19.72K | -19.23K | -18.75K | 6.37M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.83M | n/a | -4.27K | n/a | n/a | n/a | n/a | n/a | -254.96K | -568.93K | n/a | n/a | 188.1K | -582.25K | 7.57K | n/a | 3.59M | -8.03K |
Financial Cash Flow | 18.44M | 1.74M | -114.95K | 4.31M | 56.14M | -3.18K | 2.42M | 3.3M | -597.13K | 43.85M | 1.63M | -11.3M | 2.61M | 66.66M | 3.78M | 2.72M | 43.35M | 6.36M |
Net Cash Flow | 1.85M | -9.22M | -17.1M | -15.2M | 36.87M | -13.04M | -10.32M | -9.92M | -8.71M | 34.94M | -8.62M | -32.4M | -11.73M | 55.67M | -5.21M | -17.48M | 31.6M | -6.97M |
Free Cash Flow | -16.58M | -10.97M | -16.98M | -19.51M | -19.27M | -13.03M | -12.74M | -13.22M | -8.11M | -8.9M | -10.25M | -21.1M | -14.33M | -10.99M | -8.99M | -20.19M | -11.75M | -13.32M |